Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.87
-0.03 (-0.43%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Niagen Bioscience Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Niagen Bioscience stock has a target of 11, which predicts an increase of 60.12% from the current stock price of 6.87.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Niagen Bioscience is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 |
---|---|
Strong Buy | 1 |
Buy | 0 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +60.12% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
121.04M
from 99.60M
Increased by 21.53%
Revenue Next Year
146.30M
from 121.04M
Increased by 20.87%
EPS This Year
0.12
from 0.11
Increased by 8.18%
EPS Next Year
0.20
from 0.12
Increased by 68.57%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 126.1M | 155.8M | 175.0M |
Avg | 121.0M | 146.3M | 168.1M |
Low | 115.1M | 135.5M | 159.7M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 26.6% | 28.7% | 19.6% |
Avg | 21.5% | 20.9% | 14.9% |
Low | 15.5% | 12.0% | 9.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.16 | 0.26 | 0.33 |
Avg | 0.12 | 0.20 | 0.30 |
Low | 0.07 | 0.14 | 0.26 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 43.2% | 120.6% | 62.3% |
Avg | 8.2% | 68.6% | 47.5% |
Low | -37.6% | 15.3% | 31.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.